These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8021915)

  • 1. Newly discovered stereochemical requirements in the side-chain conformation of delta opioid agonists for recognizing opioid delta receptors.
    Qian X; Kövér KE; Shenderovich MD; Lou BS; Misicka A; Zalewska T; Horváth R; Davis P; Bilsky EJ; Porreca F
    J Med Chem; 1994 Jun; 37(12):1746-57. PubMed ID: 8021915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
    Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptors.
    Misicka A; Cavagnero S; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
    J Pept Res; 1997 Jul; 50(1):48-54. PubMed ID: 9273887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.
    Haaseth RC; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
    Int J Pept Protein Res; 1990 Aug; 36(2):139-46. PubMed ID: 2177042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
    Toth G; Russell KC; Landis G; Kramer TH; Fang L; Knapp R; Davis P; Burks TF; Yamamura HI; Hruby VJ
    J Med Chem; 1992 Jun; 35(13):2384-91. PubMed ID: 1320122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
    Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
    Hruby VJ; Toth G; Gehrig CA; Kao LF; Knapp R; Lui GK; Yamamura HI; Kramer TH; Davis P; Burks TF
    J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity.
    Haaseth RC; Horan PJ; Bilsky EJ; Davis P; Zalewska T; Slaninova J; Yamamura HI; Weber SJ; Davis TP; Porreca F
    J Med Chem; 1994 May; 37(11):1572-7. PubMed ID: 8201592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions.
    Chandrakumar NS; Stapelfeld A; Beardsley PM; Lopez OT; Drury B; Anthony E; Savage MA; Williamson LN; Reichman M
    J Med Chem; 1992 Aug; 35(16):2928-38. PubMed ID: 1323677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
    J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
    J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta opioid receptor-selective ligands: [D-Pen2,D-Pen5]enkephalin-dermenkephalin chimeric peptides.
    Cavagnero S; Misicka A; Knapp RJ; Davis P; Fang L; Burks TF; Yamamura HI; Hruby VJ
    Life Sci; 1991; 49(7):495-503. PubMed ID: 1650414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
    J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biology, NMR and conformation studies of the topographically constrained delta-opioid selective peptide analogs of [beta-iPrPhe(3)]deltorphin I.
    Liao S; Shenderovich M; Kövér KE; Zhang Z; Hosohata K; Davis P; Porreca F; Yamamura HI; Hurby VJ
    J Pept Res; 2001 Apr; 57(4):257-76. PubMed ID: 11328484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors.
    Salvadori S; Bryant SD; Bianchi C; Balboni G; Scaranari V; Attila M; Lazarus LH
    J Med Chem; 1993 Nov; 36(24):3748-56. PubMed ID: 8254604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
    Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly potent side chain-main chain cyclized dermorphin-deltorphin analogues: an integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling.
    Ro S; Zhu Q; Lee CW; Goodman M; Darlak K; Spatola AF; Chung NN; Schiller PW; Malmberg AB; Yaksh TL
    J Pept Sci; 1995; 1(3):157-74. PubMed ID: 9222993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
    Bilsky EJ; Qian X; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.